Search

Speech

SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC)

Deleporte, Amélie Hendlisz, Alain Garcia, Camilo Delaunoit, Thierry Maréchal, Raphaël Peeters, Marc Holbrechts, Stéphane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand Van Laethem, Jean Luc Ceyssens, Sarah Barbuto, Anna Maria Lhommel, Renaud[UCL] Demolin, Gauthier Moreau, Michel Paesmans, Marianne Piccart, Martine Flamen, Patrick (2012) ASCO Annual Meeting — Chicago, Illinois

Speech

Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.

Hendlisz, Alain Caparica, Rafael Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jozef Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Vermeij, Joanna D'Hondt, Lionel A. Geboes, Karen Paula Besse-Hammer, Tatiana Buggenhout, Alexis Paesmans, Marianne Piccart, Martine Flamen, Patrick (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (COLORECTAL) CANCER —

Speech

REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).

Bregni, Giacomo Senti, Chiara Acedo Reina, Elena Gkolfakis, Paraskevas Moretti, Luigi Veron, Ana Demetter, Pieter Liberale, Gabriel Carrasco, Javier Geboes, Karen Paula Gokburun, Yeter Peeters, Marc Van den Eynde, Marc[UCL] Van Laethem, Jean-Luc Vergauwe, Philippe Buyse, Marc E. Deleporte, Amélie Hendlisz, Alain Sclafani, Francesco (2022) 2022 ASCO Gastrointestinal Cancers Symposium —

Speech

SoMore trial: Early metabolic response assessment of a sorafenib (SOR) and capecitabine (CAP) combination in chemorefractory metastatic colorectal cancer (mCRC).

Deleporte, Amélie Hendlisz, Alain Garcia, Camilo Delaunoit, Thierry Maréchal, Raphael Peeters, Marc Holbrechts, Stephane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand[UCL] Van Laethem, Jean-Luc Rolfo, Christian Diego Diaz, Marie Lhommel, Renaud[UCL] Demolin, Gauthier Moreau, Michel Ameye, Lieveke Paesmans, Marianne Piccart-Gebhart, Martine J. Flamen, Patrick (2014) 2014 ASCO GI Annual Meeting — (United States) San Francisco, CA

Journal article

Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.

Vandeputte, Caroline Bregni, Giacomo Gkolfakis, Paraskevas Guiot, Thomas Pretta, Andrea Kehagias, Pashalina Senti, Chiara Reina, Elena Acedo Van Bogaert, Camille Deleporte, Amélie Geboes, Karen Delaunoit, Thierry Demolin, Gauthier Peeters, Marc D'Hondt, Lionel[UCL] Janssens, Jos Carrasco, Javier Holbrechts, Stephane Goeminne, Jean-Charles[UCL] Vergauwe, Philippe Van Laethem, Jean-Luc Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2021) Clinical colorectal cancer — Vol. 20, no. 4, p. 326-333 (2021)

Speech

Preoperative (preop) chemosensitivity Testing as predictor of treatment benefit in adjuvant stade III colon cancer (CC) : Interim analysis of the PEPITA study

Hendlisz, Alain Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stéphane Clausse, Marylene Vermeij, Joanna D'Hondt, Lionel[UCL] Laurent, Stéphanie Efira, André Gomez Galdon, Maria Buggenhout , Alesxis Garcia, Camilo Piccart-Gebhart, Martine J Flamen, Patrick Belgian Group for Digestive Oncology (BGDO) (2014) 2014 ASCO GI Meeting — (United States) San Francisco, CA

Speech

Preop chemosensitivity testing as predictor of adjuvant benefit in stage III colon cancer (PEPITA)

Hendlisz, Alain Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stéphane Clausse, Marylene Vermeij, Joanna D'Hondt, Lionel[UCL] Laurent, Stéphanie Efira, André Peeters, Marc Gomez Galdon, Maria Buggenhout , Alexis Paesmans, Marianne Garcia, Camilo Piccart-Gebhart, Martine J Flamen, Patrick (2014) Belgian Week of Gastroenterology - XXVIth Edition — (Belgium) La Hulpe

Journal article

Circulating DNA in the neoadjuvant setting of early stage colon cancer.

Bregni, Giacomo Pretta, Andrea Senti, Chiara Acedo Reina, Elena Vandeputte, Caroline Trevisi, Elena Gkolfakis, Paraskevas Kehagias, Pashalina Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Peeters, Marc D'Hondt, Lionel[UCL] Geboes, Karen Besse-Hammer, Tatiana Rothé, Françoise Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2022) Acta oncologica — Vol. 61, no. 10, p. 1223-1229 (2022)

Journal article

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

Borbath, Ivan[UCL] Ceratti, Antonino[UCL] Verslype, Chris Demols, Anne Delaunoit, Thierry Laurent, Stéphanie Deleporte, Amélie Vergauwe, Philippe L Van Maanen, Aline[UCL] Sempoux, Christine[UCL] Van Cutsem, Eric Van Laethem , Jean Luc Belgian Group of Digestive Oncology (2013) Annals of Oncology — Vol. 24, no.11, p. 2824-2829 (2013)

Speech

Weekly versus biweekly combination of docetaxel (d)-cisplatin (c)-5fu (f) in advanced gastric cancer and esogastric junction adenocarcinoma (agc): doge study

Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, F. Holbrechts, Stephane Delaunoit, Thierry Houbiers, Ghislain Kalantari, H. Rezaei Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Vanderauwera, J. Pierre, Pascal D'Hondt, Lionel[UCL] Ghillemijn, Bjorn Covas, Angélique Paesmans, Marianne Ameye, Lieveke Hendlisz, Alain (2014) 39th ESMO Congress (ESMO 2014) — (Spain) Madrid

Journal article

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, Frédéric Holbrechts, Stéphane Delaunoit, Thierry Houbiers, Ghislain Kalantari, Hassan R Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Van Der Auwera, Jacques D'Hondt, Lionel[UCL] Pierre, Pascal Ghillemijn, Bjorn Covas, Angelique Paesmans, Marianne Ameye, Lieveke Awada, Ahmad Sclafani, Francesco Hendlisz, Alain (2021) Cancer medicine — Vol. 10, no. 13, p. 4366-4374 (2021)

Speech

SOMORE trial: combining sorafenib with capecitabine yields highly encouraging survival results and elevated metabolic response rate in chemorefractory metastatic colorectal cancer

Deleporte, Amélie Hendlisz, Alain Delaunoit, Thierry Maréchal, Raphael Peeters, Marc Holbrecht, Stephane Van den Eynde, Marc[UCL] Houbiers, Ghislain Moreau, Michel Flamen, Patrick (2012) ESMO 2012 Congress — (Austria) Vienna

Speech

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study

Cerrati, Antonino[UCL] Borbath, Ivan[UCL] Verslype, Chris Delaunoit, Thierry Van den Eynde, Marc[UCL] Laurent, Stéphanie Peeters, Marc Hendlisz, Alain Deleporte, Amélie Vergauwe, Philippe Delhougne, Bernard Polus, Marc Van Cutsem, Eric Van Laethem, Jean-Luc (2011) Belgian Week of Gastroenterology - XXIIIrd Edition — (Belgium) Liege

Journal article

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.

Vandeputte, Caroline Kehagias, Pashalina El Housni, Hakim Ameye, Lieveke Laes, Jean-François Desmedt, Christine Sotiriou, Christos Deleporte, Amélie Puleo, Francesco Geboes, Karen Delaunoit, Thierry Demolin, Gauthier Peeters, Marc D'Hondt, Lionel[UCL] Janssens, Jos Carrasco, Javier Marechal, Raphaël Galdon, Maria Gomez Heimann, Pierre Paesmans, Marianne Flamen, Patrick Hendlisz, Alain (2018) OncoTarget — Vol. 9, no.25, p. 17756-17769 (2018)

Speech

Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC): REGARD-C study.

Hendlisz, Alain Deleporte, Amélie Delaunoit, Thierry Peeters, Marc Demolin, Gauthier Janssens, Jos Holbrechts, Stephane Maréchal, Raphael Carrasco, Javier Van den Eynde, Marc[UCL] Geboes, Karen Paula Goeminne, Jean-Charles D'Hondt, Lionel[UCL] Paesmans, Marianne Vandeputte, Caroline Hoerner, Frederic Flamen, Patrick (2014) 2014 ASCO Annual Meeting — (United States) Chicago, IL

Speech

International real-world study of total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC)

Audisio, Alexandre Leuven Rectal Cancer Group Vanden Bulcke, Alexander Van den Eynde, Marc[UCL] Dermine, Alexandre Puleo, Francesco[UCL] Diaz, Marie Gilliaux, Quentin[UCL] Deleporte, Amélie Geboes, Karen Martinive, Philippe Vandamme, Timon Hendlisz, Alain van Laethem, Johan Sclafani, Francesco (2024) 36th Belgian Week of Gastroenterology — (Belgium) Antwerpen

User menu

Author

Date

Document Type

Access

Footer Help

Languages

Footer menu